Abstract

This study evaluated the prevalence of clinical multidrug-resistant organisms (MDROs) and analyzed correlations between MDROs and patient characteristics in a regional teaching hospital of Taiwan. A retrospective comparative case-control study was conducted from January 2016 to August 2018 by collecting data from 486 hospitalized and non-hospitalized patients (M = 286, F = 200), including patient gender and age, microbial species, and antibiotic susceptibility. The results indicated that at least one MDRO was isolated from 5.3–6.3% of patients (p < 0.05), with an average age of 61.08 years. Of the MDROs strains, vancomycin-resistant enterococcus and carbapenem-resistant acinetobacter baumannii increased annually (p < 0.002 and p < 0.012, respectively). Three factors of age (over 60 years), treatment in an intensive care unit (ICU), and specimen category were statistically significant (p < 0.039, p < 0.001 and p < 0.001, respectively) and indicated that elderly patients in an ICU have a higher risk of being infected by MDROs. The outpatients infected by methicillin-resistant staphylococcus aureus (MRSA) were more frequent than inpatients, implying the existence of community-acquired MRSA strains. The results of this study could provide valuable information for the detection and colonization of multidrug-resistant organisms in hospital infection control systems.

Highlights

  • Multidrug-resistant organisms (MDROs) are pathogenic bacteria resistant to more than one kind of antibiotic [1]

  • In 2016, there was a total of 246 MDRO-infected patients with 136 methicillin-resistant Staphylococcus aureus (MRSA) infections and 43 carbapenem-resistant acinetobacter baumannii (CRAB) infections

  • First, the results of this study showed that isolation rates of CRAB and VRE are on the rise

Read more

Summary

Introduction

Multidrug-resistant organisms (MDROs) are pathogenic bacteria resistant to more than one kind of antibiotic [1]. Common MDROs include carbapenem-resistant acinetobacter baumannii (CRAB) [2], carbapenem-resistant pseudomonas aeruginosa (CRPA) [3], methicillin-resistant Staphylococcus aureus (MRSA) [4], and vancomycin-resistant enterococcus faecium (VREfm) [5]. In 1997, the antimicrobial surveillance program SENTRY [6] indicated that the proportion of drug-resistant bacteria in intestinal microbiota had substantially increased so that there were only a limited range of effective antibiotics and in some cases no suitable antibiotics for use in clinical treatments. Res. Public Health 2019, 16, 1104; doi:10.3390/ijerph16071104 www.mdpi.com/journal/ijerph

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call